Skip to content
Search

Latest Stories

'Peace of mind to pharmacists and their patients': Teva updates packaging across generics portfolio

Teva UK has begun replacing its existing packaging with a new design which is "clearer and easier to read".

The new look is "unique, recognizable and distinctive." It "enhances safety and provides a recognizable and distinguishable pack range."


One of the UK’s leading generics manufacturers, Teva UK supplies more than 500 generic pharmaceutical products to retail and hospital pharmacies.

The company says each product within the portfolio is distinguishable by color, ensuring no two different packs have the same drug and strength colors and with additional product information on the side of the pack and a simplified back, it makes it even easier to identify the correct product when dispensing and supports patients when taking their medication.

“Our medicines impact the lives of millions of people every day and our packaging is often the first touchpoint for our patients and our customers”, said Kim Innes, general manager of Teva UK and Ireland.

“We’ve updated our packaging with the dispensing process and patients in mind making packs clearer and easier to read, ensuring no two packs have the same drug and strength color, bringing peace of mind to pharmacists and their patients.”

In 2006, Teva introduced packaging designed with the end user in mind, making products on the shelf easier to distinguish and dispense. The new design, the company said, builds on this work and have been produced following extensive consultation with more than 4,000 healthcare professionals, patients and carers from around the UK and the rest of the world, as well as spending hundreds of hours engaging with our regulatory authorities.

Pharmacists can experience the pack and see the thinking behind our design changes using augmented reality by scanning a QR code which can be found across all related packaging launch materials.

The company added: "The new packaging will be applied across our whole generics portfolio, helping people understand our wider range of products and will be moved onto branded and OTC lines over the course of 2023."

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
Shadow Health Minister raised concerns about the impact of NICs hike on healthcare

Shadow Health Minister Dr Caroline Johnson MP speaking during a House of Commons debate on Wednesday

MPs slam government over national insurance hike, warn of impact on pharmacies

Shadow Health Minister Dr Caroline Johnson MP has criticised the Labour government for increasing employer National Insurance Contributions (NICs), without properly considering its effects on the wider healthcare system.

Speaking during a House of Commons debate on Wednesday, she warned of the significant strain the rise in national insurance and taxes will place on pharmacies and the wider healthcare sector.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less